| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 651.154 | 627.447 | 590.465 | 489.387 | 480.193 | 471.971 | 435.569 | 463.383 | 433.288 | 42.219 |
| Total Income - EUR | 664.308 | 636.258 | 606.362 | 493.353 | 484.069 | 476.663 | 471.455 | 466.213 | 454.422 | 436.030 |
| Total Expenses - EUR | 600.042 | 561.095 | 543.795 | 457.303 | 452.203 | 438.308 | 408.518 | 436.281 | 426.777 | 33.878 |
| Gross Profit/Loss - EUR | 64.265 | 75.163 | 62.566 | 36.050 | 31.866 | 38.355 | 62.937 | 29.931 | 27.645 | 402.152 |
| Net Profit/Loss - EUR | 52.411 | 61.551 | 52.540 | 30.982 | 27.026 | 34.065 | 58.202 | 25.288 | 23.386 | 389.333 |
| Employees | 13 | 13 | 10 | 10 | 8 | 8 | 8 | 8 | 8 | 2 |
Check the financial reports for the company - Depomed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 28.057 | 36.774 | 51.852 | 39.363 | 27.383 | 16.539 | 11.810 | 13.357 | 16.824 | 15.108 |
| Current Assets | 640.475 | 638.826 | 595.826 | 598.181 | 543.827 | 553.693 | 584.095 | 551.099 | 526.473 | 1.044.452 |
| Inventories | 93.541 | 89.505 | 79.299 | 65.806 | 91.202 | 99.169 | 84.222 | 80.429 | 0 | 0 |
| Receivables | 257.961 | 221.158 | 249.318 | 250.629 | 223.061 | 231.574 | 246.747 | 44.802 | 77.510 | 448.525 |
| Cash | 288.973 | 328.164 | 267.208 | 281.746 | 229.563 | 222.951 | 253.126 | 425.868 | 448.963 | 595.927 |
| Shareholders Funds | 555.119 | 559.132 | 541.701 | 511.166 | 497.910 | 496.023 | 509.916 | 243.182 | 265.831 | 438.196 |
| Social Capital | 225 | 223 | 219 | 215 | 211 | 207 | 202 | 203 | 202 | 201 |
| Debts | 113.413 | 116.468 | 105.976 | 126.378 | 73.299 | 74.210 | 85.989 | 321.274 | 277.466 | 621.363 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4322 - 4322" | |||||||||
| CAEN Financial Year |
4322
|
|||||||||
Comments - Depomed Srl